Vivo Capital Fund Ix, L.p. - Net Worth and Insider Trading

Vivo Capital Fund Ix, L.p. Net Worth

The estimated net worth of Vivo Capital Fund Ix, L.p. is at least $161 Million dollars as of 2024-12-27. Vivo Capital Fund Ix, L.p. is the 10% Owner of Tarsus Pharmaceuticals Inc and owns about 2,469,001 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $136 Million. Vivo Capital Fund Ix, L.p. is the 10% Owner of Instil Bio Inc and owns about 624,339 shares of Instil Bio Inc (TIL) stock worth over $13 Million. Vivo Capital Fund Ix, L.p. is also the 10% Owner of ALX Oncology Holdings Inc and owns about 4,220,048 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $7 Million. Besides these, Vivo Capital Fund Ix, L.p. also holds IO Biotech Inc (IOBT) . Details can be seen in Vivo Capital Fund Ix, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivo Capital Fund Ix, L.p. has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Vivo Capital Fund Ix, L.p.

To

Vivo Capital Fund Ix, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vivo Capital Fund Ix, L.p. owns 5 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , ALX Oncology Holdings Inc (ALXO) , and Sierra Oncology Inc (SRRA) among others .

Click here to see the complete history of Vivo Capital Fund Ix, L.p.’s form 4 insider trades.

Insider Ownership Summary of Vivo Capital Fund Ix, L.p.

Ticker Comapny Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2022-05-05 10 percent owner
ALXO ALX Oncology Holdings Inc 2020-07-21 10 percent owner
SRRA Sierra Oncology Inc 2019-11-22 10 percent owner
LIMIT LIMIT 2021-03-23 10 percent owner
LIMIT LIMIT 2023-08-09 10 percent owner

Vivo Capital Fund Ix, L.p. Latest Holdings Summary

Vivo Capital Fund Ix, L.p. currently owns a total of 4 stocks. Among these stocks, Vivo Capital Fund Ix, L.p. owns 2,469,001 shares of Tarsus Pharmaceuticals Inc (TARS) as of May 5, 2022, with a value of $136 Million and a weighting of 84.24%. Vivo Capital Fund Ix, L.p. owns 624,339 shares of Instil Bio Inc (TIL) as of March 23, 2021, with a value of $13 Million and a weighting of 7.77%. Vivo Capital Fund Ix, L.p. also owns 4,220,048 shares of ALX Oncology Holdings Inc (ALXO) as of July 21, 2020, with a value of $7 Million and a weighting of 4.24%. The other 1 stocks IO Biotech Inc (IOBT) have a combined weighting of 3.75% among all his current holdings.

Latest Holdings of Vivo Capital Fund Ix, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TARS Tarsus Pharmaceuticals Inc 2022-05-05 2,469,001 55.00 135,795,055
TIL Instil Bio Inc 2021-03-23 624,339 20.05 12,517,997
ALXO ALX Oncology Holdings Inc 2020-07-21 4,220,048 1.62 6,836,478
IOBT IO Biotech Inc 2023-08-09 6,173,439 0.98 6,049,970

Holding Weightings of Vivo Capital Fund Ix, L.p.


Vivo Capital Fund Ix, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Vivo Capital Fund Ix, L.p. has made a total of 6 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the sale of 5,374 shares on May 5, 2022, which brought Vivo Capital Fund Ix, L.p. around $65,832.

According to the SEC Form 4 filings, Vivo Capital Fund Ix, L.p. has made a total of 1 transactions in Instil Bio Inc (TIL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Instil Bio Inc is the acquisition of 15,000 shares on March 23, 2021, which cost Vivo Capital Fund Ix, L.p. around $6 Million.

According to the SEC Form 4 filings, Vivo Capital Fund Ix, L.p. has made a total of 1 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 975,000 shares on July 21, 2020, which cost Vivo Capital Fund Ix, L.p. around $19 Million.

More details on Vivo Capital Fund Ix, L.p.'s insider transactions can be found in the Insider Trading History of Vivo Capital Fund Ix, L.p. table.

Insider Trading History of Vivo Capital Fund Ix, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Vivo Capital Fund Ix, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Vivo Capital Fund Ix, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivo Capital Fund Ix, L.p. is 3.43%. GuruFocus also compares Vivo Capital Fund Ix, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivo Capital Fund Ix, L.p. within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Vivo Capital Fund Ix, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Vivo Capital Fund Ix, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.51 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.29 LIMIT LIMIT LIMIT LIMIT LIMIT

Vivo Capital Fund Ix, L.p. Ownership Network

Ownership Network List of Vivo Capital Fund Ix, L.p.

No Data

Ownership Network Relation of Vivo Capital Fund Ix, L.p.

Insider Network Chart

Vivo Capital Fund Ix, L.p. Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Vivo Capital Fund Ix, L.p. is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Vivo Capital Fund Ix, L.p. made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 203,315 shares made by Bobak R. Azamian , a net sale of 12,792 shares made by Bryan Wahl , and a net sale of 12,669 shares made by Dianne C. Whitfield .

In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 290,122 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 279,616 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Vivo Capital Fund Ix, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Vivo Capital Fund Ix, L.p.. You might contact Vivo Capital Fund Ix, L.p. via mailing address: 192 Lytton Avenue, Palo Alto Ca 94301.

Discussions on Vivo Capital Fund Ix, L.p.

No discussions yet.